Park Medi World has raised ₹276 crore from anchor investors ahead of its Initial Public Offering. The company allotted 1.70 crore shares at ₹162 per share to 23 institutional investors, including Kotak Mutual Fund, Allianz Global Investors Fund, Taurus Mutual Fund, Reliance General Insurance and Société Générale. This strong anchor participation has come a day before the public issue opens for subscription.
The IPO is valued at ₹920 crore, consisting of a ₹770 crore fresh issue and a ₹150 crore Offer for Sale by promoter Ajit Gupta. The price band has been set between ₹154 and ₹162 per share and the issue will be open for subscription from 10 to 12 December 2025.Funds raised through the IPO will be used for multiple purposes including ₹380 crore earmarked for repayment or prepayment of borrowings, ₹60.5 crore for capital expenditure to develop and expand hospitals through subsidiaries such as Park Medicity (NCR) and Blue Heavens and ₹27.45 crore for medical equipment purchases. The remaining amount will be allocated toward inorganic expansion and general corporate requirements.
Park Medi World is one of the leading hospital chains in northern India with 13 multi-super-specialty hospitals and about 3,250 beds across Haryana, Delhi, Punjab and Rajasthan. The company has a significant growth pipeline with new hospitals and expansions planned in cities including Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur and Kanpur with projects extending through 2027. The strong response from anchor investors at the top of the price band underscores market confidence in the company’s business performance and expansion strategy as it prepares for its public listing.
